Form 10-Q PUMA BIOTECHNOLOGY, INC. For: Jun 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Wall St futures pause after AI rally, focus on Mideast tensions
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Puma Biotech (PBYI) Posts Q2 adj.-Loss of $1.17/Share
August 9, 2016 4:35 PM EDTPuma Biotech (NYSE: PBYI) reported Q2 EPS of ($1.17), $1.01 better than the analyst estimate of ($2.18).
For earnings history and earnings-related data on Puma Biotech (PBYI) click here.
... More